Core Viewpoint - Eastman Chemical reported a significant decline in earnings and sales for Q3 2025, reflecting ongoing challenges in demand and market conditions [2][3][9]. Financial Performance - Q3 2025 earnings were 40 cents per share, a 74% decrease from $1.53 in the same quarter last year [2]. - Adjusted earnings were $1.14 per share, down from $2.26 year-over-year, missing the Zacks Consensus Estimate of $1.18 [2]. - Revenues for the quarter were approximately $2.2 billion, a decline of 10.6% year-over-year, also missing the consensus estimate of $2.24 billion [3]. Segment Performance - **Advanced Materials**: Sales fell 7% year-over-year to $728 million, missing estimates due to weak demand in consumer discretionary markets [4]. - **Additives & Functional Products**: Sales were $716 million, down 4% from the previous year, affected by lower sales volume in construction and auto refinish markets [5]. - **Chemical Intermediaries**: Sales decreased 16% year-over-year to $499 million, driven by weak demand in the North American construction market [6]. - **Fibers**: Sales dropped 24% year-over-year to $254 million, primarily due to lower acetate tow volume [7]. Cash Flow and Debt - The company ended the quarter with cash and cash equivalents of $489 million and net debt of approximately $4.59 billion [8]. - Operating cash flow was $402 million, reflecting a 1.5% year-over-year increase [8]. - Eastman Chemical returned $146 million to shareholders through dividends and share repurchases during the quarter [8]. Guidance and Outlook - The company anticipates a challenging macroeconomic environment with cautious customer behavior due to tariff changes and soft demand [9]. - Eastman Chemical aims to cut over $75 million in costs this year and approximately $100 million in 2026, focusing on cost-reduction initiatives and improved plant efficiency [9]. - Full-year adjusted earnings are projected to be between $5.40 and $5.65 per share, with an expected operating cash flow of around $1 billion [10]. Market Sentiment - There has been a downward trend in estimates, with a consensus estimate shift of -24.73% [11]. - Eastman Chemical currently holds a Zacks Rank 4 (Sell), indicating expectations of below-average returns in the coming months [13]. - The stock has a poor Growth Score of F and a Momentum Score of F, but a strong Value Score of A [12].

Core Insights - Eastman Chemical Company (EMN) reported first-quarter 2025 earnings of $1.57 per share, a 12.9% increase from $1.39 in the same quarter last year, with adjusted earnings of $1.91 per share, up 18.6% from $1.61, surpassing the Zacks Consensus Estimate of $1.89 [1][2] Financial Performance - Revenues for the first quarter were $2,290 million, missing the Zacks Consensus Estimate of $2,308.6 million, and reflecting a 1% decrease from $2,310 million in the prior-year quarter [2] - Cash used in operating activities totaled $167 million, and dividends paid to stockholders were $96 million [7] Segment Performance - **Advanced Materials**: Revenues fell 3.9% year over year to $719 million, missing the estimate of $763.7 million due to reduced selling prices and unfavorable sales volume mix [3] - **Additives & Functional Products**: Revenues increased 4.1% year over year to $733 million, exceeding the estimate of $703.3 million, driven by higher selling prices and improved sales volume mix [4] - **Chemical Intermediates**: Net sales rose 4.2% year over year to $545 million, beating the estimate of $533.5 million, attributed to increased selling prices and a stronger sales volume mix [5] - **Fibers**: Net sales declined 12.9% year over year to $288 million, missing the estimate of $325 million, primarily due to a less favorable sales volume mix and reduced selling prices [6] Guidance and Outlook - The company raised its cost reduction goal to approximately $75 million and lowered capital expenditures to about $550 million, indicating a strong position to manage challenges from increasing tariffs [8] - EMN anticipates generating around $1.2 billion in operating cash flow for full-year 2025, with adjusted EPS guidance for the second quarter projected between $1.70 and $1.90 [9][11] Market Performance - EMN's shares have decreased by 15.9% over the past year, compared to a 25.7% decline in its industry [12]